The impact of gender on clinical manifestations of primary antiphospholipid syndrome

Lupus

Volumn 14, Issue 8, 2005, Pages 607-612

  Jara, Luis J ^a,b   Medina, G ^a   Vera Lastra, O ^a,b   Barile, L ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

Author keywords

Clinical manifestations; Gender; Primary antiphospholipid syndrome

Indexed keywords

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HUMAN; MALE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; STROKE; SYSTEMIC LUPUS ERYTHEMATOSUS; VEIN THROMBOSIS;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEX FACTORS; SKIN DISEASES; THROMBOCYTOPENIA;

EID: 24744445029     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203305lu2176oa     Document Type: Article

References (46)

1. Gabriel SE. The epidemiology of gender-discrepant illness. Lupus 1999; 8: 339-345.
2. Lockshin MD, Gabriel S, Zakeri Z, Lockshin RA. Gender, biology and human disease: report of a conference. Lupus 1999; 8: 335-338.
3. Lahita RG. Sex hormones and systemic lupus erythematosus. Rheum Dis Clin North Am 2000; 26: 951-968.
4. Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Parks CG, Gilkeson GS. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum 1998; 41: 1714-1724.
5. Martins L, Rocha G, Rodrigues A et al. Lupus nephritis: a retrospective review of 78 cases from a single center. Clin Nephrol 2002; 57: 114-119.
6. Arbuckle MR, James JA, Dennis GJ et al. Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus. Lupus 2003; 12: 99-106.
7. Wang F, Wang CL, Tan CT, Manivasagar M. Systemic lupus erythematosus in Malaysia: study of 539 patients and comparison of prevalence and disease expression in different racial and gender groups. Lupus 1997; 6: 248-253.
8. Hughes GRV. Thrombosis, abortion, cerebral disease and the lupus anticoagulant. Br Med J 1983; 287: 1021-1023.
9. Asherson RA, Khamashta MA, Ordi-Ros J et al. The 'primary' antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989; 68: 366-374.
10. Alarcón-Segovia D, Sánchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 1989; 16: 482-488.
11. Font J, Lopez-Soto A, Cervera R et al. The 'primary' antiphospholipid syndrome: antiphospholipid antibody pattern and clinical features of a series of 23 patients. Autoimmunity 1991; 9: 69-75.
12. Vianna JL, Khamashta MA, Ordi-Ros J et al. Comparison of the primary and secondary antiphospholipid syndrome. A European Multicenter Study of 114 patients. Am J Med 1994; 96: 3-9.
13. Vincent T, Mackworth-Young C. The primary antiphospholipid syndrome. In Khamashta MA ed. Hughes syndrome, antiphospholipid syndrome. London: Springer-Verlag, 2000: 111-126.
14. Rosove MH, Brewer PMC. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992; 117: 303-308.
15. Munoz-Rodriguez FJ, Font J, Cervera R et al. Clinical study and follow-up of 100 patients with the antiphospholipid syndrome. Semin Arthritis Rheum 1999; 29: 182-190.
16. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309-1311.
17. Gharavi AE, Harris EN, Asherson RA, Hughes GR. Anticardiolipin antibodies. Isotype distribution and phospholipid specificity. Ann Rheum Dis 1987; 46: 1-6.
18. Harris EN, Gharavi AE, Asherson RA, Boey ML, Hughes GR. Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol 1984; 2: 47-51.
19. Asherson RA, Khamashta MA, Gil A et al. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med 1989; 86: 391-399.
20. Verro P, Levine SR, Tietjen GE. Cerebrovascular ischemic events with high positive anticardiolipin antibodies. Stroke 1998; 29: 2245-2253.
21. Janardhan V, Wolf PA, Kase CS, Massaro JM et al. Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack: the Framingham cohort and offspring study. Stroke 2004; 35: 736-741.
22. Ahmed SA, Verthelyi D. Antibodies to cardiolipin in normal C57BL/6J mice: induction by estrogen but not dihydrotestosterone. J Autoimmun 1993; 6: 265-279.
23. Murphy SJ, McCullough LD, Smith JM. Stroke in the female: role of biological sex and estrogen. ILAR J 2004; 45: 147-159.
24. Hadid OH, Jabir M. Hypo-estrogenemia in retinal vasculopathy due to primary antiphospholipid antibody syndrome. Eur J Ophthalmol 2003; 13: 819-821.
25. Iemolo F, Martiniuk A, Steinman DA, Spence JD. Sex differences in carotid plaque and stenosis. Stroke 2004; 35: 477-481.
26. Medina G, Casaos D, Jara LJ et al. Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome. Ann Rheum Dis 2003; 62: 607-610.
27. Ames PR, Margarita A, Sokoll KB, Weston M, Brancaccio V. Premature atherosclerosis in primary antiphospholipid syndrome. Preliminary data. Ann Rheum Dis 2005; 64: 315-317.
28. Vlachoyannopoulos PG, Kanellopoulos PG, Ioannidis JP, Tektonidou MG, Mastorakou I, Mousopoulos HM. Atheroslerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study. Rheumatology (Oxford) 2003; 42: 645-651.
29. Sanchez-Guerrero J, Reyes E, Alarcon-Segovia D. Primary antiphospholipid syndrome as a cause of intestinal infarction. J Rheumatol 1992; 19: 623-625.
30. Gul A, Inanc M, Ocal L, Konice M, Aral O, Lie JT. Primary antiphospholipid syndrome associated with mesenteric inflammatory veno-occlusive disease. Clin Rheumatol 1996; 15: 207-210.
31. Poux JM, Boudet R, Lacroix P et al. Renal infarction and thrombosis of the infrarenal aorta in a 35-year-old man with primary antiphospholipid syndrome. Am J Kidney Dis 1996; 27: 721-725.
32. Kojima E, Naito K, Iwai M, Hirose Y, Isobe K, Takano K. Antiphospholipid syndrome complicated by thrombosis of the superior mesenteric artery, co-existence of smooth muscle hyperplasia. Intern Med 1997; 36: 528-531.
33. Labarca JA, Rabaggliati RM, Radrigan FJ et al. Antiphospholipid syndrome associated with cytomegalovirus infection: case report and review. Clin Infect Dis 1997; 24: 197-200.
34. Lee HJ, Park JW, Chang JC. Mesenteric and portal venous obstruction associated with primary antiphospholipid antibody syndrome. J Gastroenterol Hepatol 1997; 12: 822-826.
35. Orth T, Mayet WJ, Wanitschke R, Hafner G, Hinkeldey K, Galle PR. Acute mesenterial artery oclussion-an unusual symptom of primary antiphospholipid antibody syndrome. Med Klin 2000; 95: 409-412.
36. Higa M, Kojima M, Ohnuma S et al. Portal and mesenteric vein and inferior vena cava thrombosis associated with antiphospholipid syndrome. Intern Med 2001; 40: 1245-1249.
37. Martinez Rubio MP, Moreno Lopez R, Lama M, Sanchez Bielsa F. Primary antiphospholipid syndrome diagnosed in hemodialysis. Nefrologia 2002; 22: 71-74.
38. Kato N, Yukioka H, Yoshida G, Kurita S, Hirakawa K, Koh KR. Superior mesenteric vein thrombosis presented transient false positivity for lupus anticoagulant under heparin treatment. Eur J Emerg Med 2002; 9: 67-70.
39. Fried M, Van Ganse W, Van Avermaet S. Mesenteric vein thrombosis triggered by blunt abdominal trauma in a patient with the primary antiphospholipid syndrome. Eur J Gastroenterol Hepatol 2002; 14: 697-700.
40. Choi BG, Jeon HS, Lee SO, Yoo WH, Lee ST, Ahn DS. Primary antiphospholipid syndrome presenting with abdominal angina and splenic infarction. Rheumatol Int 2002; 22: 119-121.
41. Espinosa G, Font J, Garcia-Pagan JC et al. Budd-Chiari syndrome secondary to antiphospholipid syndrome: clinical and immunologic characteristics of 43 patients. Medicine (Baltimore) 2001; 80: 345-354.
42. Piette JC, Cacoub P, Wechsler B. Renal manifestations of the antiphospholipid syndrome. Semin Arthritis Rheum 1994; 23: 357-366.
43. Nochy D, Daugas E, Droz D et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 1999; 10: 507-518.
44. Amigo MC, Garcia-Torres R, Robles M, Bochicchio T, Reyes PA. Renal involvement in primary antiphospholipid syndrome. J Rheumatol 1992; 19: 1181-1185.
45. Fakhouri F, Noel LH, Zuber J et al. The expanding spectrum of renal diseases associated with antiphospholipid syndrome. Am J Kidney Dis 2003; 41: 1205-1211.
46. Krnic-Barrie S, O'Connor CR, Looney SW, Pierangeli SS, Harris EN. A retrospective review of 61 patients with antiphospholipid syndrome: analysis of factors influencing recurrent thrombosis. Arch Intern Med 1997; 157: 2001-2008.